Cargando…
Four guidelines on cardiovascular complications and cardiovascular disease, prognosis and treatment in COVID‑19
Autores principales: | Siebelink, H. J., Jansen, C. W., Belfroid, E., Hoogervorst-Schilp, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047573/ https://www.ncbi.nlm.nih.gov/pubmed/33856657 http://dx.doi.org/10.1007/s12471-021-01570-x |
Ejemplares similares
-
Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients
por: Jewbali, L. S. D., et al.
Publicado: (2021) -
Effect of anticoagulant therapy in COVID-19 patients
por: Tieleman, R. G., et al.
Publicado: (2021) -
The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients
por: van Kimmenade, R. R. J., et al.
Publicado: (2021) -
How often and to what extent do admitted COVID-19 patients have signs of cardiac injury?
por: Habets, M. A. W., et al.
Publicado: (2021) -
COVID-19 and the Cardiovascular System: Requiem for a Medical Minotaur
por: Koupenova, Milka, et al.
Publicado: (2023)